Growth Vault

When you're spinning out of academia or launching your first science-driven startup, it's easy to default to what you know: experiments, validation, technical depth. 👉 But here's the reality biotech founders often overlook: 👉 If you're still running your company like a research project, you're not actually building a biotech company. This isn't a criticism of your science. It's a call to elevate it. Because what works in a lab doesn't automatically work in a business. And u

While you’re waiting for quarterly reports to tell you what’s happening in your market, your competitors already know. They’re tracking...

This is the mistake almost every ambitious leader makes on the road to real growth. In today’s fast-paced world, leaders and founders are...

Most biotech CEOs act like science is a lottery. The edge isn’t predicting biology—it’s running unlimited, budget-disciplined experiments. This memo outlines why building a Continuous Experiment Engine is now the only viable path to scale, investor readiness, and a genuine competitive advantage.

Investors in 2025 aren’t just backing biotech science—they’re judging execution. CEOs who can’t show scaling signals—operational rhythm, cross-team clarity, and a real scalability narrative—risk burning credibility, not just capital. This memo breaks down the three signals biotech leaders must master to win trust and funding.

In biotech, science alone isn’t enough to win. You can have the most groundbreaking therapy in the pipeline, but if you lose public...

Biotech CEOs don’t fail because the science breaks. They fail because operations can’t scale. Here’s why operational discipline, not IP, determines who raises at Series B and beyond.

Every successful business starts with a spark, a founder’s idea, energy, and relentless drive. But there comes a point in almost every...

👉 Scaling up is the critical inflection point for any biotech company. While achieving early success as a startup is a significant...

Let’s be honest, sometimes business just gets hard. Not the kind of hard that comes from a slow week, but the kind that hits you out of...

The AI Buzz Is Real But So Is the Strategy Gap 👉 AI is dominating the biotech conversation right now. Every founder is eager to...

For most founders, the dream isn’t just to build a successful company it’s to create a self-sustaining business that thrives...

In the fast-evolving world of biotech, having a brilliant idea is only the first step. Transforming that idea into a scalable company ...

If you’re an entrepreneur, you’ve probably heard countless times that you need to network more. Investors remind you. Advisors insist on...

Biotech founders are doers by necessity. The clock is ticking, the science is demanding, and the runway is already shrinking. Pitch...

Most founders think their company’s future is shaped by the visible: Revenue numbers Market size Competitors But the truth is simpler —...

In Biotech, Certainty Is a Mirage Scientific training primes founders to seek certainty . Hypothesize, experiment, validate — it’s a...

Delegation as a Growth Tool Every biotech startup eventually reaches a breaking point. In the earliest days, the founder often wears...

Artificial intelligence has officially crossed from buzzword to boardroom. Every pitch deck seems to mention it. Every investor panel...

If your company still operates the same way it did three years ago, you’re already behind. The pace of change in biotech has never been...